Lanxess Faces Investor Pullback Amid Restructuring Challenges

JPMorgan reduces stake in Lanxess below 5% as the German chemicals group faces weak demand, implements cost cuts including 550 job losses, and forecasts a subdued 2026.

A major U.S. financial institution has scaled back its stake in the German specialty chemicals group Lanxess. JPMorgan Chase & Co. has reduced its holding below the regulatory disclosure threshold of 5%, a move made public today concerning a transaction dated March 30, 2026. This divestment occurs as the company navigates a demanding operational landscape.

JPMorgan's total voting rights position now stands at 4.54%, down from its previous holding of 5.49%. A notable detail within this reduction is the decline in its direct shareholding, which fell from 1.40% to 0.85%, placing it significantly below the one percent mark. The remainder of the position is held through financial instruments, which also decreased from 4.09% to 3.69%.

Restructuring Efforts Intensify

The timing of this share sale aligns with a period of profound transformation for Lanxess. The company's financial performance for the 2025 fiscal year showed considerable strain, with revenue declining by nearly 11% to approximately €5.67 billion. This slump has been attributed to persistently weak market demand and ongoing competitive price pressure originating from Asia.

In response, CEO Matthias Zachert has implemented a more rigorous cost-saving initiative. The program aims to achieve annual savings of €100 million by 2028. Planned measures include the elimination of 550 positions globally, with about two-thirds of these job cuts affecting its German workforce. Additionally, a 35-hour work week will be introduced in certain operational areas.

Cautious Forecast and Financial Position

Management's outlook for the current year, 2026, does not anticipate an immediate rebound. The company projects its adjusted EBITDA to land in a range between €450 million and €550 million, with any material improvement unlikely before the second half of the year. Potential support may arise from government-led infrastructure stimulus programs.

On a positive note, Lanxess has made progress in strengthening its balance sheet. By the close of 2025, net financial debt was reduced by 15% to around €2.02 billion. This deleveraging was aided by the divestment of its Urethane Systems business unit. Furthermore, the board has proposed a dividend of €0.10 per share for 2025, a largely symbolic gesture of continuity that underscores the challenging operating environment.